4//SEC Filing
Sankar Subramanian 4
Accession 0001808805-22-000101
CIK 0001808805other
Filed
Sep 27, 8:00 PM ET
Accepted
Sep 28, 4:01 PM ET
Size
7.0 KB
Accession
0001808805-22-000101
Insider Transaction Report
Form 4
Sankar Subramanian
Senior VP, Product Development
Transactions
- Purchase
Common Stock
2022-09-27$2.03/sh+5,000$10,149→ 91,250 total - Purchase
Common Stock
2022-09-26$2.02/sh+10,000$20,250→ 86,250 total
Footnotes (3)
- [F1]Represents the weighted average share price of an aggregate total of 10,000 shares purchased in the price range of $2.00 to $2.05 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F2]Includes 1,250 shares of Common Stock acquired on June 1, 2022 through the Issuer's 2021 Employee Stock Purchase Plan.
- [F3]Represents the weighted average share price of an aggregate total of 5,000 shares purchased in the price range of $2.02 to $2.04 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Documents
Issuer
Nautilus Biotechnology, Inc.
CIK 0001808805
Entity typeother
Related Parties
1- filerCIK 0001856744
Filing Metadata
- Form type
- 4
- Filed
- Sep 27, 8:00 PM ET
- Accepted
- Sep 28, 4:01 PM ET
- Size
- 7.0 KB